Clinical trial
Depiction of Delayed Enhancement in Patients With Documented Myocardial…
NCT00310544 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00310544 |
|---|---|
| Title | Depiction of Delayed Enhancement in Patients With Documented Myocardial Infarction |
| Official title | Multicenter, Single-blind, Randomized, Intraindividual Study of the Safety and Efficacy of Magnevist Gadopentetate Dimeglumine (Magnevist® Injection) at 0.1 and 0.2 mmol/kg for the Depiction of Delayed Enhancement in Patients With Documented Myocardial Infarction |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Myocardial Infarction |
| Intervention type | Drug |
| Interventions | Magnevist (Gadopentetate dimeglumine, BAY86-4882) |
| Enrollment | 73 |
| Start date | Mar 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Apr 4, 2006 |
| Last update posted | Dec 15, 2014 |
| Countries | Argentina, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: